Picture of CTC Bio logo

060590 CTC Bio Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for CTC Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7,9786,040-15,588-5,2203,241
Depreciation
Amortisation
Non-Cash Items5,8428,12914,0785,516605
Unusual Items
Other Non-Cash Items
Changes in Working Capital2,311-2,6513,779-1,703-5,994
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities6,45718,2248,2164,4964,383
Capital Expenditures-1,674-3,173-1,885-2,139-787
Purchase of Fixed Assets
Other Investing Cash Flow Items3,827151232-1,0821,042
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities2,153-3,022-1,653-3,221255
Financing Cash Flow Items-2,591-1,840-2,317-2,852-13,566
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-13,3691,617-6,003-7,263-7,049
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4,75916,538676-5,458-2,421